Literature DB >> 11054831

HPLC enantiomeric resolution of novel aromatase inhibitors on cellulose- and amylose-based chiral stationary phases under reversed phase mode.

H Y Aboul-Enein1, I Ali, G Gübitz, C Simons, P J Nicholls.   

Abstract

The chiral resolution of seven aromatase inhibitors (four triazole derivatives (Ia, Ib, Ic, and Id) and three tetrazole derivatives (IIa, IIb, and IIc)) was achieved on Chiralcel OJ-R [cellulose tris (4-methyl benzoate)], Chiralcel OD-RH [cellulose tris (3,5-dimethylphenyl carbamate)], and Chiralpak AD-RH [amylose tris (3,5-dimethylphenyl carbamate)] chiral stationary phases. The mobile phases used were A: 2-PrOH-MeCN (90:10, v/v); B: 2-PrOH-MeCN (50:50, v/v); C: MeCN-H(2)O (50:50, v/v); D: MeCN-H(2)O (80:20, v/v); and E: MeCN-H(2)O (95:05, v/v). The flow rate was 0.5 mL/min for all the mobile phases. The resolution capability of these chiral stationary phases were in the order Chiralpak AD-RH > Chiralcel OD-RH > Chiralcel OJ-R. The values of alpha and Rs of the resolved enantiomers of the aromatase inhibitors varied from 1.02-5.63 and 1. 12-6.72, respectively. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11054831     DOI: 10.1002/1520-636X(2000)12:10<727::AID-CHIR5>3.0.CO;2-T

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  4 in total

Review 1.  Clinical pharmacokinetics of aromatase inhibitors and inactivators.

Authors:  Per Lønning
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 2.  Aromatase inhibitors and inactivators for breast cancer therapy.

Authors:  Per E Lønning
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

3.  Separation and determination of acetyl-glutamine enantiomers by HPLC-MS and its application in pharmacokinetic study.

Authors:  Xiaoxiao Zhang; Lei Gao; Zunjian Zhang; Yuan Tian
Journal:  J Pharm Anal       Date:  2017-06-13

4.  Enantioselective HPLC Analysis to Assist the Chemical Exploration of Chiral Imidazolines.

Authors:  Bruno Cerra; Antonio Macchiarulo; Andrea Carotti; Emidio Camaioni; Ina Varfaj; Roccaldo Sardella; Antimo Gioiello
Journal:  Molecules       Date:  2020-02-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.